Abstract
Background and aims: Reduced maternal placental growth factor (PlGF) and higher soluble fms-like tyrosine kinase (sFlt-1) concentrations in pregnancy may have persistent effects on offspring vasculature. We hypothesized that suboptimal maternal angiogenic factors in pregnancy may adversely affect fetal vascular development, leading to an increased risk of adverse atheriosclerotic adaptations and higher blood pressure in offspring. Methods: In a population-based prospective cohort among 4565 women and their offspring, we examined the associations of maternal serum PlGF and sFlt-1 concentrations in the first half of pregnancy with offspring vascular development. We measured childhood blood pressure and obtained childhood carotid intima media thickness and carotid distensibility through ultrasonography at 9 years. Results: After adjustment for maternal sociodemographic and lifestyle characteristics, no associations were present of maternal first and second trimester angiogenic factors with childhood blood pressure, carotid intima media thickness (IMT) or distensibility in the total population. In preterm born children only, higher maternal second trimester PlGF concentrations, but not sFlt-1 concentrations, were associated with a lower childhood diastolic blood pressure (difference: -0.16 SDS (95% CI -0.30, −0.03) per SDS increase in maternal second trimester PlGF concentration). No associations among children born small-for-gestational age were present. Conclusions: In a low-risk population, maternal angiogenic factors in the first half of pregnancy are not associated with childhood blood pressure, carotid IMT or carotid distensibility after considering maternal socio-demographic and lifestyle factors. Only in children born preterm, lower maternal second trimester PlGF concentrations are associated with higher childhood diastolic blood pressure, but not with other vascular outcomes.
Original language | English |
---|---|
Pages (from-to) | 46-54 |
Number of pages | 9 |
Journal | Atherosclerosis |
Volume | 338 |
Early online date | 6 Nov 2021 |
DOIs | |
Publication status | Published - 1 Dec 2021 |
Bibliographical note
Funding Information:The Generation R Study is financially supported by the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development. Romy Gaillard received funding from the Dutch Heart Foundation (grant number 2017T013), the Dutch Diabetes Foundation (grant number 2017.81.002), the Netherlands Organization for Health Research and Development (NWO, ZonMW, grant number 543003109) and from the European Union's Horizon 2020 research and innovation programme under the ERA-NET Cofund action (no 727565), EndObesity, ZonMW the Netherlands (no. 529051026). Vincent Jaddoe received a grant from the Netherlands Organization for Health Research and Development (NWO, ZonMw-VIDI 016.136.361) and a European Research Council Consolidator Grant (ERC-2014-CoG-648916).
Funding Information:
The Generation R Study is financially supported by the Erasmus Medical Center , Rotterdam , the Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development . Romy Gaillard received funding from the Dutch Heart Foundation (grant number 2017T013 ), the Dutch Diabetes Foundation (grant number 2017.81.002 ), the Netherlands Organization for Health Research and Development (NWO , ZonMW, grant number 543003109 ) and from the European Union's Horizon 2020 research and innovation programme under the ERA-NET Cofund action (no 727565 ), EndObesity, ZonMW the Netherlands (no. 529051026 ). Vincent Jaddoe received a grant from the Netherlands Organization for Health Research and Development ( NWO , ZonMw-VIDI 016.136.361 ) and a European Research Council Consolidator Grant ( ERC-2014-CoG-648916 ).
Publisher Copyright:
© 2021 The Authors
Research programs
- EMC MM-04-54-08-A